spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Actelion 

 HSMN NewsFeed - 12 Oct 2021
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2021
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2020
MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Feb 2020
Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2019
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2018
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2018
Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 6 Sep 2017
Actelion Receives FDA Approval Of TRACLEER(R) (bosentan) For Use In Pediatric Patients With Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2017
Johnson & Johnson Announces Completion of Acquisition of Actelion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2016
Johnson & Johnson Announces it has Ended Discussions with Actelion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jul 2015
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2014
Novimmune Appoints Andrew J. Oakley as CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2014
NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2013
Immune Pharmaceuticals Announces Changes to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic
 HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2013
Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma in Patients Who Have Received Prior Skin-Directed Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jun 2013
Middle Peak Medical Raises $8.5 M to Develop Novel Mitral Valve Technology
Devices Cardiology Venture Capital
 HSMN NewsFeed - 26 Feb 2013
Bausch & Lomb Names Robert Bertolini President And Chief Financial Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2012
Theratechnologies Provides Regulatory Update on Tesamorelin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology
 HSMN NewsFeed - 15 May 2012
New Executive Vice President Commercial Appointed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2011
Portola Pharmaceuticals Appoints Dr. James Topper to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Aug 2010
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI(R) (epoprostenol for injection) for Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Secures $12.4 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 May 2010
NOXXON Pharma AG raises 33 million in Series D Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2010
Actelion Pharmaceuticals Announces Commercial Availability of Epoprostenol for Injection for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2009
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
Devices Monitoring Licensing Endocrinology
 HSMN NewsFeed - 20 Jun 2008
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
Biopharmaceuticals
 HSMN NewsFeed - 20 May 2008
GlycoVaxyn Appoints Philippe Dro as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2007
Actelion Provides Update On Bosentan in Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2007
Actelion: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 1 Nov 2007
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2007
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2007
Actelion Ltd: Miglustat (Zavesca) Receives Negative Opinion From the European Committee For Medicinal Products For Human Use For Extension of Indication For Niemann Pick Type C
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 4 Oct 2007
Alvine Pharmaceuticals Announces Management Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2007
New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential to Restore Normal Physiological Sleep in Patients Suffering From Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2007
Alvine Pharmaceuticals Appoints Abhay Joshi, Ph.D. to President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2007
Bosentan (Tracleer) Receives EU Approval for Reduction of Number of New Digital Ulcerations in Systemic Sclerosis Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 May 2007
Peplin Appoints Chief Commercial Officer
Biopharmaceuticals Dermatology Oncology Personnel
 HSMN NewsFeed - 26 Mar 2007
Bosentan -- Tracleer -- Receives Positive EU Opinion for Reduction of New Digital Ulcerations in Systemic Sclerosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2007
Thomas L. Feldman Joins POINT Biomedical as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 5 Mar 2007
Actelion: Positive Study With Bosentan (Tracleer) in CTEPH
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2007
Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Successful Proof-of-Concept With Actelion's Orexin Receptor Antagonist in Patients Suffering From Primary Insomnia -- First Demonstration of Key Role of Orexin System in Humans Suffering From Sleep Disorders
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Successful Study With Tracleer(r) in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2006
Actelion-1 -- First Tissue-Targeting Endothelin Receptor Antagonist -- in Phase III for Pulmonary Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2006
Actelion Ltd. Announces Commencement of Cash Tender Offer for CoTherix, Inc. and HSR Clearance to Acquire CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2006
Actelion Ltd: Detailed Analysis of CONSCIOUS-1 Presented at CNS
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 May 2006
Actelion: ATS Presentation Highlights Strong Rationale for a Morbidity/Mortality Study with Bosentan in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 20

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 20 additional stories matching:
Actelion
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.